Cargando…
In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
Cowpea mosaic virus (CPMV) is currently in the development pipeline for multiple biomedical applications, including cancer immunotherapy. In particular the application of CPMV as in situ vaccine has shown promise; here the plant viral nanoparticle is used as an adjuvant and is injected directly into...
Autores principales: | Chariou, Paul L., Beiss, Veronique, Ma, Yifeng, Steinmetz, Nicole F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323807/ https://www.ncbi.nlm.nih.gov/pubmed/34368764 http://dx.doi.org/10.1039/d0ma00752h |
Ejemplares similares
-
Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
por: Kerstetter-Fogle, Amber, et al.
Publicado: (2019) -
Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy
por: Gautam, Aayushma, et al.
Publicado: (2021) -
Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo
por: Gonzalez, Maria J., et al.
Publicado: (2009) -
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin
por: Koudelka, Kristopher J., et al.
Publicado: (2009)